The federal Centers for Medicare and Medicaid Services (CMS) on Tuesday released a list of 10 drugs that will be part of the Medicare price-setting Drug Price Negotiation Program that was established via the Inflation Reduction Act.
The selected drug list for the first round, according to CMS, includes Eliquis, Jardiance, Xarelto, Januvia, Enbrel, Farxiga, Entresto, Imbruvica, and Stelara, as well as multiple types of Novo Nordisk’s Fiasp. They include Fiasp FlexTouch, Fiasp PenFill, NovoLog, NovoLog FlexPen, and NovoLog PenFill.
